Suchergebnisse - "Colangeli, Vincenzo"

PubPharm (111)

1

Improvement in insulin sensitivity after switching from an integrase inhibitor-based regimen to doravirine/tenofovir disoproxil fumarate/lamivudine in people with significant weight gain

enthalten in: HIV medicine | 2024

von Calza, L. | Giglia, M. | Colangeli, V. | +3

2

Efficacy and Safety of Switching to Dolutegravir/Lamivudine in Virologically Suppressed People Living with HIV-1 Aged Over 65 Years

enthalten in: AIDS research and human retroviruses | 2024

von Calza, L. | Colangeli, V. | Legnani, G. | +3

3

Doravirine/lamivudine/tenofovir disoproxil fumarate in virologically suppressed people living with HIV : A real-life experience

enthalten in: International journal of STD & AIDS | 2023

von Calza, L. | Colangeli, V. | Pensalfine, G. | +4

4

Weight gain in treatment-naive HIV-1 infected patients starting abacavir/lamivudine/dolutegravir or tenofovir alafenamide/emtricitabine/bictegravir

enthalten in: AIDS (London, England) | 2022

von Calza, L. | Borderi, M. | Colangeli, V. | +5

5

COVID-19 in patients with HIV-1 infection : a single-centre experience in northern Italy

enthalten in: Infection | 2021

von Calza, L. | Bon, I. | Tadolini, M. | +9

6

Short Communication : No Significant Changes in Weight and Body Fat Mass in Suppressed HIV-Infected Patients Switched to Dual Combination Lamivudine Plus Dolutegravir or Raltegravir

enthalten in: AIDS research and human retroviruses | 2021

von Calza, L. | Borderi, M. | Colangeli, V. | +5

CommentIn: AIDS Res Hum Retroviruses. 2021 May;37(5):333-334. - PMID 33587009

7

Rosuvastatin decreases serum inflammatory markers and slows atherosclerosis progression rate in treated HIV-infected patients with metabolic syndrome

enthalten in: Infectious diseases (London, England) | 2021

von Calza, L. | Colangeli, V. | Borderi, M. | +5

8

Short Communication : No Significant Increase in Body Fat Mass in Naive HIV-Infected Patients Starting Raltegravir Plus Tenofovir Disoproxil Fumarate/Emtricitabine

enthalten in: AIDS research and human retroviruses | 2021

von Calza, L. | Borderi, M. | Colangeli, V. | +4

9

COVID-19 Outcomes in Patients With Uncontrolled HIV-1 Infection

enthalten in: Journal of acquired immune deficiency syndromes (1999) | 2021

von Calza, L. | Bon, I. | Borderi, M. | +4

10

Simplification to dual therapy containing lamivudine and raltegravir or dolutegravir in HIV-infected patients on virologically suppressive antiretroviral therapy

enthalten in: The Journal of antimicrobial chemotherapy | 2020

von Calza, L. | Colangeli, V. | Borderi, M. | +5

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[12]